FDA Approved: OLANZAPINE — Supplemental Application (Jubilant Cadista Pharmacuticals Inc.)

View source ↗

Summary

FDA approves Jubilant Cadista Pharmaceuticals Inc.'s supplemental application for olanzapine, enabling a generic olanzapine product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Schizophrenia

Drugs mentioned

• olanzapine (olanzapine)

Snippet

SUPPL AP for OLANZAPINE (OLANZAPINE)